Serum soluble Fas level as a prognostic factor in patients with gynecological malignanciesKONNO, Ryo; TAKANO, Tadao; SATO, Shinji et al.Clinical cancer research. 2000, Vol 6, Num 9, pp 3576-3580, issn 1078-0432Article

Midkine and its clinical significance in endometrial carcinomaTANABE, Kojiro; MATSUMOTO, Mitsuyo; YAEGASHI, Nobuo et al.Cancer science. 2008, Vol 99, Num 6, pp 1125-1130, issn 1347-9032, 6 p.Article

A phase I study of irinotecan and pegylated liposomal doxorubicin in recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study)SHOJI, Tadahiro; TAKATORI, Eriko; NISHIYAMA, Hiroshi et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 5, pp 895-901, issn 0344-5704, 7 p.Article

Expression of retinoic acid receptors in human endometrial carcinomaTANABE, Kojiro; UTSUNOMIYA, Hiroki; HAYASHI, Shin-Ichi et al.Cancer science. 2008, Vol 99, Num 2, pp 267-271, issn 1347-9032, 5 p.Article

A phase II multicenter trial of concurrent chemoradiotherapy with weekly nedaplatin in advanced uterine cervical carcinoma : Tohoku Gynecologic Cancer Unit StudyYOKOYAMA, Yoshihito; TAKANO, Tadao; TANAKA, Toshinobu et al.Oncology reports. 2008, Vol 19, Num 6, pp 1551-1556, issn 1021-335X, 6 p.Article

Expression of vasohibin as a novel endothelium-derived angiogenesis inhibitor in endometrial cancerYOSHINAGA, Kousuke; KIYOSHILTO; MORIYA, Takuya et al.Cancer science. 2008, Vol 99, Num 5, pp 914-919, issn 1347-9032, 6 p.Article